Beyond the absolute contraindications, several situations call for heightened caution in the class framing and are firmly a clinicians domain: a history of pancreatitis or symptomatic gallstones, significant gastrointestinal motility disorders (such as gastroparesis, which slowed gastric emptying can worsen), diabetic retinopathy that is not stabilized, severe renal impairment where dehydration from GI side effects raises risk, and any concurrent use of insulin or a sulfonylurea, where the additive glucose-lowering can produce hypoglycemia
Jemperli is also the first immuno-oncology treatment and PD-1 inhibitor to be authorized for frontline use in this patient population
10.1016/s0006-8993(00)02816-x 33 KangE
Reduce neuroinflammation, a key driver of brain aging
The majority of BPC-157 animal studies used direct injection into injury sites with sample sizes of 8-12 animals per group
Science 246 , 382385 (1989)